Susan Leight

University of Pennsylvania — United States

Medicine · Health Sciences

20h-index4.9kcitations30works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(21), Dementia and Cognitive Impairment Research(5), Parkinson's Disease Mechanisms and Treatments(4), Nuclear Receptors and Signaling(4), Neurological Disease Mechanisms and Treatments(4)

Publications30 total

Comparison of xMAP and ELISA Assays for Detecting Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Journal of Alzheimer s Disease·2012· 79 cited
Intraneuronal APP, Not Free Aβ Peptides in 3xTg-AD Mice: Implications for Tau versus Aβ-Mediated Alzheimer Neurodegeneration
Journal of Neuroscience·2011· 97 citedOpen Access
Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia
Neurology·2010· 101 citedOpen Access
Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration
Journal of Neuroscience·2008· 446 citedOpen Access
P2‐098: Comparison of diagnostics values of cerebrospinal fluid tau and structural magnetic resonance imaging in classifying patients with Alzheimer's disease versus normal subjects
Alzheimer s & Dementia·2008Open Access
CSF biomarkers in frontotemporal lobar degeneration with known pathology
Neurology·2008· 213 citedOpen Access
Cellular localization of Nicastrin affects amyloid β species production
FEBS Letters·2008· 9 citedOpen Access
Title Page / Table of Contents
Neurosignals·2007Open Access
Biomarkers for Early Detection of Alzheimer Pathology
Neurosignals·2007· 92 citedOpen Access
Cortical biochemistry in MCI and Alzheimer disease
Neurology·2007· 54 cited
Pesticide Exposure Exacerbates α-Synucleinopathy in an A53T Transgenic Mouse Model
American Journal Of Pathology·2007· 131 citedOpen Access
Nursing center annual reports: Value and content
Journal of the American Academy of Nurse Practitioners·2007· 1 cited
Commentary on “Optimal design of clinical trials for drugs designed to slow the course of Alzheimer℉s disease.” Biochemical biomarkers of late‐life dementia
Alzheimer s & Dementia·2006· 12 citedOpen Access
P4–004: Microdialysis reveals β–amyloid levels in brain interstitial fluid regulated by γ–secretase and neprilysin inhibitors as well as overexpression of β–secretase in vivo
Alzheimer s & Dementia·2006
P2–207: Cortical biochemical markers of mild cognitive impairment
Alzheimer s & Dementia·2006
Impaired Rapid Eye Movement Sleep in the Tg2576 APP Murine Model of Alzheimer's Disease with Injury to Pedunculopontine Cholinergic Neurons
American Journal Of Pathology·2005· 92 citedOpen Access
Reply
Annals of Neurology·2005
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease
Annals of Neurology·2005· 227 cited
Cerebrospinal Fluid Tau and β-Amyloid
Archives of Neurology·2003· 361 cited
Repetitive Mild Brain Trauma Accelerates Aβ Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis
Journal of Neuroscience·2002· 340 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

John Q. Trojanowski(22), Virginia M.‐Y. Lee(20), Mark S. Forman(7), Christopher M. Clark(6), Kunihiro Uryu(5), Domenico Praticò(5), Benoit I. Giasson(4), Robert W. Doms(3), Sharon X. Xie(3), Owen A. Ross(3), Bin Zhang(3), Christos Davatzikos(3), Takeshi Iwatsubo(2), David G. Cook(2), Jesse Chittams(2), Murray Grossman(2), Jennifer Farmer(2), Michel Goedert(2), V. M.-Y. Lee(2), Ralf Hoffmann(2)